Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States.
about
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers.Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers.Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.Screening for tuberculosis and the use of a borderline zone for the interpretation of the interferon-γ release assay (IGRA) in Portuguese healthcare workersChallenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.Serial IGRA testing of trainees in the healthcare sector in a country with low incidence for tuberculosis - a prospective cohort study.Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.IFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers.Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.QuantiFERON-TB Gold in-tube testing for tuberculosis in healthcare professionals.Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges.Cumulative False-Positive QuantiFERON-TB Interferon-γ Release Assay Results.
P2860
Q21133739-77EA96B8-F47E-41CB-9009-0CBB1B5CC9D2Q33760728-F3ABF76F-F74E-4897-BF21-C33A728E050EQ33792760-1433050D-532E-49D2-9BAF-1F2677350D3DQ34776030-7D320DD5-5CBB-455A-B4FB-120C8DED34F7Q36161757-B8172122-DF3A-434C-ABA8-4F7B72F242E8Q36585190-1942D5CE-A09A-4E7C-B51D-08DF8DB8FB2FQ37304401-9D73C53B-F4DA-4D17-B593-BC5B135B5C10Q37378565-5E214963-852F-45BE-817B-353EFCF05E7DQ37544916-8DB8CB32-08A2-4063-A638-E81B83A5DEB9Q38180469-AC057AD8-985B-457E-86EC-C0637E2ABC04Q40596209-50A05816-9DB6-4379-BD63-0785FD16A214Q42205033-4814DFA8-6CBF-4619-BD61-0E24016051A3Q43196415-D634319C-A44F-4381-863D-746D1041BCAFQ48066031-D2B15AC8-4992-4B89-A48F-CAE48BF1802D
P2860
Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Use of interferon-gamma releas ...... e centre in the United States.
@ast
Use of interferon-gamma releas ...... e centre in the United States.
@en
type
label
Use of interferon-gamma releas ...... e centre in the United States.
@ast
Use of interferon-gamma releas ...... e centre in the United States.
@en
prefLabel
Use of interferon-gamma releas ...... e centre in the United States.
@ast
Use of interferon-gamma releas ...... e centre in the United States.
@en
P2093
P2860
P356
P1476
Use of interferon-gamma releas ...... e centre in the United States.
@en
P2093
Gail L Woods
Manish Joshi
Thomas P Monson
P2860
P356
10.1155/2012/576324
P407
P577
2012-03-01T00:00:00Z